Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
Year: 2011
Type: article
Study design: Observational Study
Source: British Journal of Dermatology
Authors: R. Gniadecki, K. Kragballe, T.N. Dam, L. Skov
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2145492843
